Acceptance of Telemedicine in Dermatology Patients, Physicians and Medical Staff

NCT ID: NCT04495036

Last Updated: 2020-08-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

683 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-07-01

Study Completion Date

2020-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to investigate the current use and intention to use of teledermatology in Swiss dermatology patients, dermatologists, other physicians and medical staff.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Telemedicine, the use of telecommunication and information technology to provide clinical health care from a distance, has become an increasing role in basic medical care internationally. Telemedicine is particularly suitable for skin diseases. In order to improve the use of evidence-based telemedicine, the Swiss patients' preferences regarding teledermatology versus face-to-face consultations and the patients' and physicians' determinants of acceptance for teledermatology are investigated in this study. Dermatology patients are asked to complete a newly-created 21-items-survey; Swiss dermatologists, other physicians and medical staff on telemedicine will complete a similar newly-created, 23-items-questionnaire. A descriptive statistical analysis (e.g. gender, age, place of residence (city or country), waiting time) will be performed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermatologic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

dermatology patients

data collection (21-items-patient descriptive survey)

Intervention Type OTHER

Dermatology patients are asked to complete a 21-items-survey while waiting for the doctor's consultation. Following variables will be addressed:

* Demographic data of telemedicine users and non-users
* Subjective disease perception of the dermatology patients
* Use of internet, telemedicine and telemedicine insurance model
* Patients´ willingness for additional features of telemedicine
* Advantages and disadvantages telemedicine and face-to-face consultation
* Suitable fields of dermatology for telemedicine from the patient's perspective
* Recommended structure of telemedical services by users and non-users

physicians and medical staff

data collection (23-items-physician descriptive survey)

Intervention Type OTHER

To obtain the view of Swiss dermatologists, other physicians and medical staff on telemedicine a 23-items-survey will be completed. Following variables will be addressed:

* Objective disease perception of the treating dermatologist (regarding the urgency of the patient's medical examination, the functional impairment and cosmetic burden due to patient's disease, the impairment of life quality due to patient's disease and the estimation of the course of the patient's disease)
* Suitable fields of dermatology for telemedicine from the physician's and medical staff's perspective

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

data collection (21-items-patient descriptive survey)

Dermatology patients are asked to complete a 21-items-survey while waiting for the doctor's consultation. Following variables will be addressed:

* Demographic data of telemedicine users and non-users
* Subjective disease perception of the dermatology patients
* Use of internet, telemedicine and telemedicine insurance model
* Patients´ willingness for additional features of telemedicine
* Advantages and disadvantages telemedicine and face-to-face consultation
* Suitable fields of dermatology for telemedicine from the patient's perspective
* Recommended structure of telemedical services by users and non-users

Intervention Type OTHER

data collection (23-items-physician descriptive survey)

To obtain the view of Swiss dermatologists, other physicians and medical staff on telemedicine a 23-items-survey will be completed. Following variables will be addressed:

* Objective disease perception of the treating dermatologist (regarding the urgency of the patient's medical examination, the functional impairment and cosmetic burden due to patient's disease, the impairment of life quality due to patient's disease and the estimation of the course of the patient's disease)
* Suitable fields of dermatology for telemedicine from the physician's and medical staff's perspective

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients treated in the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich
* dermatologists, other physicians and medical staff of the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Basel, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lara Valeska Maul, Dr. med.

Role: PRINCIPAL_INVESTIGATOR

Department of Dermatology, University Hospital Basel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kantonsspital Aarau

Aarau, , Switzerland

Site Status

Department of Dermatology, University Hospital Basel

Basel, , Switzerland

Site Status

University Hospital Zürich

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Maul LV, Jahn AS, Pamplona GSP, Streit M, Gantenbein L, Muller S, Nielsen ML, Greis C, Navarini AA, Maul JT. Acceptance of Telemedicine Compared to In-Person Consultation From the Providers' and Users' Perspectives: Multicenter, Cross-Sectional Study in Dermatology. JMIR Dermatol. 2023 Aug 11;6:e45384. doi: 10.2196/45384.

Reference Type DERIVED
PMID: 37582265 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Req-2019-00523; sp20Maul2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.